Supporting transformational treatments for rare disorders

A Rare Disease Day retrospective

Transforming patient care through cell and gene therapy

Cell therapy advances highlighted during The ONE Forum 2020

6 Considerations When Evaluating Cell Sourcing Vendors

Including questions to ask potential cell sourcing partners

How CAR-T reimbursement discussions help advance the field

Proposed IPPS rule an encouraging step towards a clearer payment process

5 Qualities to Seek in Your Cell Therapy Supply Chain Vendor

Considerations to help lower your cell or gene therapy logistics risk

Overcoming autologous cell therapy logistics challenges in the age of COVID-19

Experienced team for managed logistics is key

Can cell therapies unlock the COVID-19 mystery?

The promise of MSC therapies to treat deadly manifestations of cytokine storms

How COVID-19 is changing the production of cell therapies

Implementation of contingency plans allows for continued progress in therapy development

Managing donor collections during the COVID-19 pandemic

Why a diverse apheresis center network is critical to business continuity